BrainScan Webinar: Blood Biomarkers for Earlier Alzheimer’s Detection

In this July 16 webinar, Dr. Dale Bredesen is joined by Dr. Hans Frykman and Chris Coward to discuss BrainScan and the growing role of blood-based biomarkers in identifying Alzheimer’s-related changes earlier. The conversation explains how p-tau217, GFAP, and NfL provide complementary information about amyloid and tau pathology, neuroinflammation, and neuronal damage. Dr. Frykman reviews the research and technology behind the testing, while the panel discusses the different p-tau217 ranges and what they may indicate about disease progression.

The speakers also explain how to interpret results without unnecessary alarm, when retesting or specialized imaging may be helpful, and how BrainScan can complement the ReCODE Protocol by identifying signs of neurodegeneration while additional testing investigates potential contributors to cognitive decline. The webinar concludes with audience questions about weight loss, vascular dementia, traumatic brain injury, and the next generation of blood biomarkers, including more sensitive testing currently in development.

Watch Here: